Importantly, the activation of CA9 expression depends on the HIF-1α transcription factor activation cascade [54,55], which has been identified as a hypoxia-dependent gene that is relevant for the stem cell niche in GB, in which GB cells or GSCs can survive tumor-targeted therapies [55,56]. The gene discussed is HIF1A; the disease is neoplasm.